Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Fibrosis Due to NASH”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Ended earlyNCT01672866
What this trial is testing

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 222
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Testing effectiveness (Phase 2)Study completedNCT03449446
What this trial is testing

Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 395
Not applicableActive Not RecruitingNCT05740358
What this trial is testing

Liver Cirrhosis Network Cohort Study

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+9 more
Northwestern University 1,222
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Not applicableNot Yet RecruitingNCT06797596
What this trial is testing

Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

Who this might be right for
Liver Fibrosis Due to NASHMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseAlcohol Liver Disease
Fibronostics USA, Inc 100
Testing effectiveness (Phase 2)Looking for participantsNCT05832229
What this trial is testing

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 256
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Testing effectiveness (Phase 2)UnknownNCT06005012
What this trial is testing

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Who this might be right for
Fibrosis, LiverType 2 Diabetes Mellitus in ObeseNon-Alcoholic Fatty Liver Disease
University of California, San Diego 120